Mollie Pett's Contact Details

Mollie Pett's Company Details

Lipogems International S.p.A.

, , IT • 5 - 9 Employees
BioTech/Drugs

Lipogems' vision is to bring responsible, effective medical technologies to physicians and patients.Lipogems strives to provide physicians and patients with adipose tissue solutions to help maintain or restore patient lifestyles and to improve quality of life and recovery times. These solutions may offer another option to those who may not want, or who are not candidates for, major, invasive surgery. Lipogems may also be used with surgery. Lipogems International has developed and patented a disposable sterile device (CE Marked Class IIa) for close-circuit, single-step processing of lipoaspirates. In the United States, Lipogems system is 510(k) cleared and is indicated for the harvest, concentration, and transfer of autologous adipose tissue. The system meets new FDA guidelines for minimal manipulation and is intended for homologous use. The company is based in Milan, Italy and Norcross, Georgia, USA. Lipogems is distributed in 27 countries around the world. Ethical Code: Through our Ethical Code and close collaboration with many important international research centers reinforce the integrity in our approach to healthcare professionals and patient care. Partnership to Make a Difference In Healthcare: Physicians, Surgeons, and Scientific Researchers to aim to improve Patients' lives all over the world by providing Innovative Technologies and Medical solutionsFor more information, please visit www.lipogems.eu and www.understandlipogems.com and follow us on Facebook at Lipogems International.